iA Global Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.5M Sell
26,653
-2,668
-9% -$2.7M 0.35% 66
2025
Q4
$31.5M Buy
29,321
+3,657
+14% +$3.5M 0.4% 56
2025
Q3
$19.6M Buy
25,664
+2,100
+9% +$1.56M 0.27% 76
2025
Q2
$18.4M Sell
23,564
-966
-4% -$751K 0.28% 71
2025
Q1
$20.3M Sell
24,530
-180
-0.7% -$150K 0.35% 58
2024
Q4
$19.1M Buy
24,710
+2,570
+12% +$2.13M 0.33% 55
2024
Q3
$19.6M Sell
22,140
-240
-1% -$216K 0.34% 59
2024
Q2
$20.3M Sell
22,380
-540
-2% -$432K 0.39% 54
2024
Q1
$17.8M Buy
22,920
+130
+0.6% +$92.5K 0.36% 57
2023
Q4
$13.3M Sell
22,790
-2,280
-9% -$1.33M 0.31% 73
2023
Q3
$13.5M Buy
25,070
+1,330
+6% +$685K 0.36% 68
2023
Q2
$11.1M Buy
+23,740
New +$9.96M 0.3% 69

Other funds holding LLY

iA Global Asset Management's LLY Position: Q1 2026 in Review

iA Global Asset Management reduced its Eli Lilly (LLY) stake by 9.1% in Q1 2026, selling an estimated $2.7M and leaving 26,653 shares worth $24.5M. The position accounts for 0.35% of the portfolio, ranked #66.

iA Global Asset Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $31.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • iA Global Asset Management held 26,653 shares of Eli Lilly worth $24.5M as of Q1 2026.
  • iA Global Asset Management sold 2,668 Eli Lilly shares in Q1 2026, an estimated $2.7M.
  • Eli Lilly made up 0.35% of iA Global Asset Management's portfolio in Q1 2026, its #66 holding.
  • iA Global Asset Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • iA Global Asset Management's Eli Lilly position peaked at $31.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.